- Home
- MULN vs OGEN Comparison
MULN vs OGEN Comparison
Compare MULN & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MULN
- OGEN
- Stock Information
- Founded
- MULN 2014
- OGEN 1996
- Country
- MULN United States
- OGEN United States
- Employees
- MULN N/A
- OGEN N/A
- Industry
- MULN Auto Manufacturing
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- MULN Consumer Discretionary
- OGEN Health Care
- Exchange
- MULN Nasdaq
- OGEN Nasdaq
- Market Cap
- MULN 4.1M
- OGEN 4.5M
- IPO Year
- MULN N/A
- OGEN N/A
- Fundamental
- Price
- MULN $2.54
- OGEN $0.32
- Analyst Decision
- MULN
- OGEN
- Analyst Count
- MULN 0
- OGEN 0
- Target Price
- MULN N/A
- OGEN N/A
- AVG Volume (30 Days)
- MULN 5.6M
- OGEN 738.8K
- Earning Date
- MULN 08-12-2024
- OGEN 11-13-2024
- Dividend Yield
- MULN N/A
- OGEN N/A
- EPS Growth
- MULN N/A
- OGEN N/A
- EPS
- MULN N/A
- OGEN N/A
- Revenue
- MULN $156,570.00
- OGEN N/A
- Revenue This Year
- MULN N/A
- OGEN N/A
- Revenue Next Year
- MULN N/A
- OGEN N/A
- P/E Ratio
- MULN N/A
- OGEN N/A
- Revenue Growth
- MULN N/A
- OGEN N/A
- 52 Week Low
- MULN $1.60
- OGEN $0.28
- 52 Week High
- MULN $2,100.00
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- MULN 37.23
- OGEN 41.16
- Support Level
- MULN $1.60
- OGEN $0.30
- Resistance Level
- MULN $3.68
- OGEN $0.43
- Average True Range (ATR)
- MULN 0.47
- OGEN 0.03
- MACD
- MULN 0.72
- OGEN 0.01
- Stochastic Oscillator
- MULN 45.19
- OGEN 23.47
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.